Cargando…
Mass testing and treatment for malaria in low transmission areas in Amhara Region, Ethiopia
BACKGROUND: In areas with ongoing malaria transmission, strategies to clear parasites from populations can reduce infection and transmission. The objective of this paper was to describe a malaria mass testing and treatment (MTAT) intervention implemented in six kebeles (villages) in Amhara Region, E...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890322/ https://www.ncbi.nlm.nih.gov/pubmed/27255330 http://dx.doi.org/10.1186/s12936-016-1333-3 |
_version_ | 1782435102798643200 |
---|---|
author | Scott, Callie A. Yeshiwondim, Asnakew K. Serda, Belendia Guinovart, Caterina Tesfay, Berhane H. Agmas, Adem Zeleke, Melkamu T. Guesses, Girma S. Ayenew, Asmamaw L. Workie, Worku M. Steketee, Richard W. Earle, Duncan Bezabih, Belay Getachew, Asefaw |
author_facet | Scott, Callie A. Yeshiwondim, Asnakew K. Serda, Belendia Guinovart, Caterina Tesfay, Berhane H. Agmas, Adem Zeleke, Melkamu T. Guesses, Girma S. Ayenew, Asmamaw L. Workie, Worku M. Steketee, Richard W. Earle, Duncan Bezabih, Belay Getachew, Asefaw |
author_sort | Scott, Callie A. |
collection | PubMed |
description | BACKGROUND: In areas with ongoing malaria transmission, strategies to clear parasites from populations can reduce infection and transmission. The objective of this paper was to describe a malaria mass testing and treatment (MTAT) intervention implemented in six kebeles (villages) in Amhara Region, Ethiopia, at the beginning of the 2014 transmission season. METHODS: Intervention kebeles were selected based on incidence of passively detected Plasmodium falciparum and mixed (P. falciparum and P. vivax) malaria cases during the 2013 malaria transmission season. All households in intervention kebeles were targeted; consenting residents received a rapid diagnostic test (RDT) and RDT-positive individuals received artemether-lumefantrine for P. falciparum/mixed infections or chloroquine for P. vivax. Data were collected on MTAT participation, sociodemographic characteristics, malaria risk factors, and RDT positivity. RESULTS: Of 9162 households targeted, 7974 (87.0 %) participated in the MTAT. Among the 35,389 residents of these households, 30,712 (86.8 %) received an RDT. RDT-positivity was 1.4 % (0.3 % P. vivax, 0.7 % P. falciparum, 0.3 % mixed), ranging from 0.3 to 5.1 % by kebele; 39.4 % of RDT-positive individuals were febrile, 28.5 % resided in the same household with another RDT-positive individual, 23.0 % were not protected by vector control interventions [mosquito net or indoor residual spray (IRS)], and 7.1 % had travel history. For individuals under 10 years of age, the odds of being RDT-positive was significantly higher for those with fever, recent use of anti-malarial drugs or residing in the same household with another RDT-positive individual; 59.0 % of RDT-positive individuals had at least one of these risk factors. For individuals 10 years of age and older, the odds of being RDT positive was significantly higher for those with reported travel, fever, recent use of anti-malarial drugs, no use of vector control, and those residing in the same household as another RDT-positive individual; 71.2 % of RDT-positive individuals had at least one of these risk factors. CONCLUSIONS: In the Ethiopia setting, an MTAT intervention is operationally feasible and can be conducted with high coverage. RDT-positivity is low and varies widely by kebele. While several risk factors are significantly associated with RDT-positivity, there are still many RDT-positive individuals who do not have any of these risk factors. Strategies that target populations for testing and treatment based on these risk factors alone are likely to leave many infections undetected. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12936-016-1333-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4890322 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-48903222016-06-03 Mass testing and treatment for malaria in low transmission areas in Amhara Region, Ethiopia Scott, Callie A. Yeshiwondim, Asnakew K. Serda, Belendia Guinovart, Caterina Tesfay, Berhane H. Agmas, Adem Zeleke, Melkamu T. Guesses, Girma S. Ayenew, Asmamaw L. Workie, Worku M. Steketee, Richard W. Earle, Duncan Bezabih, Belay Getachew, Asefaw Malar J Research BACKGROUND: In areas with ongoing malaria transmission, strategies to clear parasites from populations can reduce infection and transmission. The objective of this paper was to describe a malaria mass testing and treatment (MTAT) intervention implemented in six kebeles (villages) in Amhara Region, Ethiopia, at the beginning of the 2014 transmission season. METHODS: Intervention kebeles were selected based on incidence of passively detected Plasmodium falciparum and mixed (P. falciparum and P. vivax) malaria cases during the 2013 malaria transmission season. All households in intervention kebeles were targeted; consenting residents received a rapid diagnostic test (RDT) and RDT-positive individuals received artemether-lumefantrine for P. falciparum/mixed infections or chloroquine for P. vivax. Data were collected on MTAT participation, sociodemographic characteristics, malaria risk factors, and RDT positivity. RESULTS: Of 9162 households targeted, 7974 (87.0 %) participated in the MTAT. Among the 35,389 residents of these households, 30,712 (86.8 %) received an RDT. RDT-positivity was 1.4 % (0.3 % P. vivax, 0.7 % P. falciparum, 0.3 % mixed), ranging from 0.3 to 5.1 % by kebele; 39.4 % of RDT-positive individuals were febrile, 28.5 % resided in the same household with another RDT-positive individual, 23.0 % were not protected by vector control interventions [mosquito net or indoor residual spray (IRS)], and 7.1 % had travel history. For individuals under 10 years of age, the odds of being RDT-positive was significantly higher for those with fever, recent use of anti-malarial drugs or residing in the same household with another RDT-positive individual; 59.0 % of RDT-positive individuals had at least one of these risk factors. For individuals 10 years of age and older, the odds of being RDT positive was significantly higher for those with reported travel, fever, recent use of anti-malarial drugs, no use of vector control, and those residing in the same household as another RDT-positive individual; 71.2 % of RDT-positive individuals had at least one of these risk factors. CONCLUSIONS: In the Ethiopia setting, an MTAT intervention is operationally feasible and can be conducted with high coverage. RDT-positivity is low and varies widely by kebele. While several risk factors are significantly associated with RDT-positivity, there are still many RDT-positive individuals who do not have any of these risk factors. Strategies that target populations for testing and treatment based on these risk factors alone are likely to leave many infections undetected. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12936-016-1333-3) contains supplementary material, which is available to authorized users. BioMed Central 2016-06-02 /pmc/articles/PMC4890322/ /pubmed/27255330 http://dx.doi.org/10.1186/s12936-016-1333-3 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Scott, Callie A. Yeshiwondim, Asnakew K. Serda, Belendia Guinovart, Caterina Tesfay, Berhane H. Agmas, Adem Zeleke, Melkamu T. Guesses, Girma S. Ayenew, Asmamaw L. Workie, Worku M. Steketee, Richard W. Earle, Duncan Bezabih, Belay Getachew, Asefaw Mass testing and treatment for malaria in low transmission areas in Amhara Region, Ethiopia |
title | Mass testing and treatment for malaria in low transmission areas in Amhara Region, Ethiopia |
title_full | Mass testing and treatment for malaria in low transmission areas in Amhara Region, Ethiopia |
title_fullStr | Mass testing and treatment for malaria in low transmission areas in Amhara Region, Ethiopia |
title_full_unstemmed | Mass testing and treatment for malaria in low transmission areas in Amhara Region, Ethiopia |
title_short | Mass testing and treatment for malaria in low transmission areas in Amhara Region, Ethiopia |
title_sort | mass testing and treatment for malaria in low transmission areas in amhara region, ethiopia |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890322/ https://www.ncbi.nlm.nih.gov/pubmed/27255330 http://dx.doi.org/10.1186/s12936-016-1333-3 |
work_keys_str_mv | AT scottcalliea masstestingandtreatmentformalariainlowtransmissionareasinamhararegionethiopia AT yeshiwondimasnakewk masstestingandtreatmentformalariainlowtransmissionareasinamhararegionethiopia AT serdabelendia masstestingandtreatmentformalariainlowtransmissionareasinamhararegionethiopia AT guinovartcaterina masstestingandtreatmentformalariainlowtransmissionareasinamhararegionethiopia AT tesfayberhaneh masstestingandtreatmentformalariainlowtransmissionareasinamhararegionethiopia AT agmasadem masstestingandtreatmentformalariainlowtransmissionareasinamhararegionethiopia AT zelekemelkamut masstestingandtreatmentformalariainlowtransmissionareasinamhararegionethiopia AT guessesgirmas masstestingandtreatmentformalariainlowtransmissionareasinamhararegionethiopia AT ayenewasmamawl masstestingandtreatmentformalariainlowtransmissionareasinamhararegionethiopia AT workieworkum masstestingandtreatmentformalariainlowtransmissionareasinamhararegionethiopia AT steketeerichardw masstestingandtreatmentformalariainlowtransmissionareasinamhararegionethiopia AT earleduncan masstestingandtreatmentformalariainlowtransmissionareasinamhararegionethiopia AT bezabihbelay masstestingandtreatmentformalariainlowtransmissionareasinamhararegionethiopia AT getachewasefaw masstestingandtreatmentformalariainlowtransmissionareasinamhararegionethiopia |